- Home
- HLP vs PRE Comparison
HLP vs PRE Comparison
Compare HLP & PRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HLP
- PRE
- Stock Information
- Founded
- HLP 2021
- PRE 2014
- Country
- HLP China
- PRE Hong Kong
- Employees
- HLP N/A
- PRE N/A
- Industry
- HLP Industrial Machinery/Components
- PRE Biotechnology: Laboratory Analytical Instruments
- Sector
- HLP Industrials
- PRE Industrials
- Exchange
- HLP Nasdaq
- PRE Nasdaq
- Market Cap
- HLP 110.2M
- PRE 105.4M
- IPO Year
- HLP 2023
- PRE N/A
- Fundamental
- Price
- HLP $1.00
- PRE $9.35
- Analyst Decision
- HLP
- PRE Buy
- Analyst Count
- HLP 0
- PRE 1
- Target Price
- HLP N/A
- PRE $9.00
- AVG Volume (30 Days)
- HLP 117.3K
- PRE 37.0K
- Earning Date
- HLP 06-19-2025
- PRE 06-17-2025
- Dividend Yield
- HLP N/A
- PRE N/A
- EPS Growth
- HLP N/A
- PRE N/A
- EPS
- HLP N/A
- PRE N/A
- Revenue
- HLP $14,105,620.00
- PRE $30,621,000.00
- Revenue This Year
- HLP N/A
- PRE $148.70
- Revenue Next Year
- HLP N/A
- PRE $82.89
- P/E Ratio
- HLP N/A
- PRE N/A
- Revenue Growth
- HLP N/A
- PRE 40.83
- 52 Week Low
- HLP $0.72
- PRE $3.10
- 52 Week High
- HLP $2.25
- PRE $11.99
- Technical
- Relative Strength Index (RSI)
- HLP 40.21
- PRE 69.16
- Support Level
- HLP $0.87
- PRE $9.14
- Resistance Level
- HLP $1.01
- PRE $11.99
- Average True Range (ATR)
- HLP 0.15
- PRE 0.84
- MACD
- HLP -0.05
- PRE 0.19
- Stochastic Oscillator
- HLP 21.05
- PRE 61.68
About HLP Hongli Group Inc.
Hongli Group Inc is a cold roll formed steel profile manufacturer in China. It customizes and manufactures cold roll formed steel profiles for machinery and equipment in a variety of sectors, including but not limited to mining and excavation, construction, agriculture and transportation.
About PRE Prenetics Global Limited
Prenetics Global Ltd is a health sciences company dedicated to consumer and clinical health. Its consumer initiative is led by IM8, a new health and wellness brand, and Europa, a U.S. sports distribution company. The clinical division is led by Insighta, focused on multi-cancer early detection technologies. This is followed by ACT Genomics, which has achieved FDA clearance for genomic profiling of solid tumors, and CircleDNA, which uses NGS to offer DNA tests. Each Prenetics unit impacts health by 'enhancing life through science'.